Search

Your search keyword '"Salvarani C."' showing total 1,744 results

Search Constraints

Start Over You searched for: Author "Salvarani C." Remove constraint Author: "Salvarani C."
1,744 results on '"Salvarani C."'

Search Results

1. Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan

3. OP0014 TRANSCRIPTS EXPRESSED IN TEMPORAL ARTERY BIOPSIES ASSOCIATED WITH RESPONSE TO THERAPY IN PATIENTS WITH GIANT CELL ARTERITIS

4. POS0115 EOSINOPHILIC GIANT CELL ARTERITIS: A DIFFERENT SUBSET OF DISEASE?

5. POS0932 AORTIC INVOLVEMENT IN GCA: A MULTICENTER RETROSPECTIVE STUDY

7. POS0604 JAKi’S SURVIVAL RATE AND PREDICTORS OF DISCONTINUATION IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS

8. AB1261 AVACOPAN IN THE TREATMENT OF ANCA-ASSOCIATED VASCULITIS: MULTICENTER PROSPECTIVE REAL-LIFE STUDY ON EFFICACY, SAFETY, AND IMPACT ON QUALITY OF LIFE

9. POS1428 GIANT CELL ARTERITIS SIGNS AND SYMPTOMS LEXICON: AN INTERNATIONAL EXPERT CONSENSUS

12. OP0025 GENOME-WIDE DNA METHYLATION STUDY REVEALS SPECIFIC SIGNATURES IN THE AFFECTED ARTERIAL TISSUE OF GIANT CELL ARTERITIS PATIENTS

14. AB0595 DIFFERENCES BETWEEN SELECTIVE AND UNSELECTIVE JAKi: RESULTS FROM A MULTICENTRIC, REAL LIFE STUDY CARRIED OUT ON PATIENTS WITH RA

16. POS0082 DEVELOPMENT OF A DIAGNOSTIC PREDICTION MODEL FOR GIANT CELL ARTERITIS: SEQUENTIAL APPLICATION OF SOUTHEND GCA PROBABILITY SCORE AND ULTRASONOGRAPHY

19. Heritable and non-heritable uncommon causes of stroke

20. The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus

21. Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial

22. Effectiveness of Pegylated Interferon Alpha-2a in Post-Uveitic Macular Edema Previously Responding to Non-Pegylated Interferon.

23. Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years

24. Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan

25. The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases

26. Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis

27. Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology

28. Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan

29. Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology

31. AB0773 IMPROVING ADHERENCE TO TREATMENT IN BEHÇET’S DISEASE - THE MULTI-STAKEHOLDER IMPACT_BD INTERNATIONAL STUDY

34. AB0771 FEMALE GENDER AND STEROID TREATMENT AS MAIN INFLUENCING FACTORS IN THE PERCEPTION OF QUALITY OF LIFE IN ANCA-ASSOCIATED VASCULITIS: FINAL RESULTS FROM THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE

35. POS0855 EVOLUTION OF RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE IN PATIENTS TREATED WITH JAK INHIBITORS: A MULTICENTER RETROSPECTIVE STUDY

36. POS0730 PROGNOSTIC FACTORS AND EFFICACY OF DMARD USE IN GCA: RESULTS FROM THE PROSPECTIVE, LONGITUDINAL,MULTI-CENTRE HAS-GCA STUDY

37. POS0722 EFFECTS ON SOLUBLE IMMUNE CHECKPOINTS INDUCED BY TOCILIZUMAB MONOTHERAPY AFTER ULTRA-SHORT-TERM GLUCOCORTICOIDS IN LARGE VESSEL – GIANT CELL ARTERITIS PATIENTS

38. AB1114 MUSCULOSKELETAL ULTRASOUND BASELINE ASSESSMENT IMPROVES THE RESPONSE TO APREMILAST IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A MULTICENTER STUDY

39. OP0102 IDENTIFICATION OF NEW RISK LOCI AND PATHWAYS INVOLVED IN GCA PATHOGENESIS BY A GENOME-WIDE STUDY

40. AB1101 THERAPEUTIC EFFECTS OF APREMILAST ON ENTHESITIS AND DACTYLITIS IN REAL CLINICAL SETTING: AN ITALIAN MULTICENTER STUDY

41. AB0789 AVACOPAN IN THE REAL-LIFE PRACTICE: EVALUATION OF EFFICACY, SAFETY, AND IMPACT ON QUALITY OF LIFE IN THE EARLY STAGES OF TREATMENT

42. AB1103 UPADACITINIB REAL-LIFE EFFICACY AND SAFETY IN PSORIATIC ARTHRITIS: RESULTS AT 24 WEEKS OF A MULTICENTRIC ITALIAN STUDY (UP-REAL)

43. POS1176 HOSPITALIZATION RATES, FEATURES, AND DISCHARGE DIAGNOSES OF A LARGE NATIONWIDE COHORT OF ANCA-ASSOCIATED VASCULITIS

45. POS0731 SOUTHEND GCA PROBABILITY SCORE (GCAPS) AND ULTRASOUND HALO SCORE (HS) AS MARKERS FOR DIAGNOSIS AND MONITORING OF GCA: RESULTS FROM THE PROSPECTIVE, MULTICENTER HAS-GCA STUDY

47. POS0714 TREAT-TO-TARGET RECOMMENDATIONS IN GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA

48. AB1105 LONG-TERM SAFETY OF IXEKIZUMAB TREATMENT IN ADULT PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS, OR AXIAL SPONDYLOARTHRITIS: A POST-HOC ANALYSIS OF END-OF-STUDY PROGRAM DATA RELATING TO MAJOR ADVERSE CARDIOVASCULAR EVENTS

49. POS0711 DEVELOPMENT OF THE TAKAYASU’S ARTERITIS INTEGRATED DISEASE ACTIVITY INDEX

50. AB0452 SURVIVAL RATE OF BARICITINIB IN A LARGE COHORT OF RHEUMATOID ARTHRITIS PATIENTS: ANALYSIS OF REAL-WORLD DATA

Catalog

Books, media, physical & digital resources